Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitously expressed prefoldin-like chaperone (UXT) is a small, highly conserved protein involved in the regulation of androgen receptor-dependent transcription, apoptosis, autophagy, and immune signaling[3][4][6]. UXT acts as a nuclear and cytoplasmic chaperone, regulating transcriptional complexes—including those for NF-κB and androgen receptor—and interacting with key factors in programmed cell death, cellular proteostasis (including autophagy via p62/SQSTM1), and the maintenance of centrosome structure[1][2][4][6]. UXT is widely expressed, with enhanced or altered expression implicated in tumorigenesis and neurodegenerative pathologies[1][3][4]. Multiple isoforms exist, with distinct cellular locations and functions in death receptor signaling and gene regulation[3][4]. There are currently no clinically validated drugs that directly target UXT, and its essential cellular roles indicate safety challenges if it were considered for therapeutic targeting[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitously expressed prefoldin-like chaperone (UXT).